Global site navigation

France to 're-shore' production of 50 key medicines: Macron
Business and Economy

France to 're-shore' production of 50 key medicines: Macron

by  AFP 2 min read
Up to 80 percent of familiar medications like antibiotics and painkillers used in France are produced abroad, especially in China
Up to 80 percent of familiar medications like antibiotics and painkillers used in France are produced abroad, especially in China. Photo: ERIC GAILLARD / POOL/AFP
Source: AFP

PAY ATTENTION: Empowering lives, one story at a time. Briefly News launched a YouTube channel Briefly TV. Subscribe now!

France will bring home production of around 50 crucial medications for which it currently depends on imports, President Emmanuel Macron said Tuesday, hoping to battle shortages of items like antibiotics and paracetamol.

Of the initial slate of drugs with a "clear dependence on imports from outside the EU", 25 "will have their production re-shored or significantly increased... in the coming weeks," Macron said during a visit to a pharmaceuticals factory in southern France.

The announcement comes after a March survey by pollsters BVA found 37 percent of people had already run into shortages at the pharmacy.

Up to 80 percent of familiar medications like antibiotics and painkillers used in France are produced abroad, especially in China.

Some of the drugs are still made in France, but at volumes that fail to match demand.

Read also

Initial Heathrow strikes suspended after new pay offer

Over the winter, Europe faced shortages of key antibiotic amoxicillin and other medications as surging illnesses particularly among children have increased demand for the drugs.

PAY ATTENTION: Follow Briefly News on Twitter and never miss the hottest topics! Find us at @brieflyza!

Under Macron's plan, public money to the tune of 160 million euros ($173 million) will go to support eight of the new projects, including for amoxycillin -- produced by British pharma giant GSK in northwestern France -- as well as anaesthetics, painkillers and cancer drugs.

Companies would be able to apply for a share of a further 50 million euros in funding, Macron said.

The 50 drugs flagged by Macron are among a list of 450 drawn up by the health ministry for which "we must absolutely secure our supply chains, either by completely re-shoring or diversifying (supply) and continuing to innovate," the president said.

Tuesday's pharma announcements mark the first step in a week dedicated to industrial projects, which Macron hopes will move public attention on from the battles over his widely-disliked pension reform.

Source: AFP

Authors:
AFP avatar

AFP AFP text, photo, graphic, audio or video material shall not be published, broadcast, rewritten for broadcast or publication or redistributed directly or indirectly in any medium. AFP news material may not be stored in whole or in part in a computer or otherwise except for personal and non-commercial use. AFP will not be held liable for any delays, inaccuracies, errors or omissions in any AFP news material or in transmission or delivery of all or any part thereof or for any damages whatsoever. As a newswire service, AFP does not obtain releases from subjects, individuals, groups or entities contained in its photographs, videos, graphics or quoted in its texts. Further, no clearance is obtained from the owners of any trademarks or copyrighted materials whose marks and materials are included in AFP material. Therefore you will be solely responsible for obtaining any and all necessary releases from whatever individuals and/or entities necessary for any uses of AFP material.

Hot: